Old Web
English
Sign In
Acemap
>
authorDetail
>
Sepideh Nemat
Sepideh Nemat
Janssen-Cilag
Gastroenterology
Placebo
Siltuximab
Multiple myeloma
Internal medicine
2
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized, Double-blind, Placebo-controlled, Multicenter Study of Siltuximab in High-risk Smoldering Multiple Myeloma
2019
Clinical Cancer Research
Timothy A. Brighton
Amit Khot
Simon J. Harrison
David Ghez
Brendan M. Weiss
Andres Kirsch
Hila Magen
Mercedes Gironella
Albert Oriol
Matthew Streetly
Britte Kranenburg
Xiang Qin
Rajesh Bandekar
Peter Hu
Mary Guilfoyle
Ming Qi
Sepideh Nemat
Hartmut Goldschmidt
Show All
Source
Cite
Save
Citations (25)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Patients with High-Risk Smoldering Multiple Myeloma
2017
Blood
Timothy A. Brighton
Simon J. Harrison
David Ghez
Brendan M. Weiss
Andreas Kirsch
Hila Magen
Mercedes Gironella
Albert Oriol
Matthew Streetly
Xiang Qin
Rajesh Bandekar
Peter Hu
Ming Qi
Sepideh Nemat
Hartmut Goldschmidt
Show All
Source
Cite
Save
Citations (6)
1